Suppr超能文献

通过聚集增强剂对tau蛋白重复结构域构象集合的重塑。

Remodeling of the conformational ensemble of the repeat domain of tau by an aggregation enhancer.

作者信息

Akoury Elias, Mukrasch Marco D, Biernat Jacek, Tepper Katharina, Ozenne Valery, Mandelkow Eckhard, Blackledge Martin, Zweckstetter Markus

机构信息

Department for NMR-based Structural Biology, Max Planck Institute for Biophysical Chemistry, Göttingen, 37077, Germany.

German Center for Neurodegenerative Diseases (DZNE), Bonn, 53175, Germany.

出版信息

Protein Sci. 2016 May;25(5):1010-20. doi: 10.1002/pro.2911. Epub 2016 Mar 24.

Abstract

Misfolding of the microtubule-associated protein Tau is a hallmark of Alzheimer disease and several other neurodegenerative disorders. Because of the dynamic nature of the Tau protein, little is known about the changes in Tau structure that occur during misfolding. Here we studied the structural consequences upon binding of the repeat domain of Tau, which plays a key role in pathogenic aggregation, to an aggregation enhancer. By combining NMR experiments with molecular simulations we show that binding of the aggregation enhancer polyglutamic acid remodels the conformational ensemble of Tau. Our study thus provides insight into an early event during misfolding of Tau.

摘要

微管相关蛋白Tau的错误折叠是阿尔茨海默病和其他几种神经退行性疾病的标志。由于Tau蛋白的动态性质,人们对错误折叠过程中Tau结构的变化知之甚少。在这里,我们研究了Tau的重复结构域(在致病性聚集中起关键作用)与聚集增强剂结合后的结构后果。通过将核磁共振实验与分子模拟相结合,我们表明聚集增强剂聚谷氨酸的结合重塑了Tau的构象集合。因此,我们的研究为Tau错误折叠过程中的早期事件提供了见解。

相似文献

6
Folding of the repeat domain of tau upon binding to lipid surfaces.tau蛋白重复结构域与脂质表面结合后的折叠。
J Mol Biol. 2006 Sep 15;362(2):312-26. doi: 10.1016/j.jmb.2006.07.018. Epub 2006 Jul 15.
10
Structural characterization of binding of Cu(II) to tau protein.铜(II)与tau蛋白结合的结构表征
Biochemistry. 2008 Oct 14;47(41):10841-51. doi: 10.1021/bi8008856. Epub 2008 Sep 20.

引用本文的文献

1
Transient Structural Properties of the Rho GDP-Dissociation Inhibitor.Rho GDP 解离抑制剂的瞬态结构特性。
Angew Chem Int Ed Engl. 2024 Aug 19;63(34):e202403941. doi: 10.1002/anie.202403941. Epub 2024 Jul 24.
2
Deciphering the therapeutical potentials of rosmarinic acid.解析迷迭香酸的治疗潜力。
Sci Rep. 2022 Sep 15;12(1):15489. doi: 10.1038/s41598-022-19735-y.
5
NMR Studies of Tau Protein in Tauopathies.tau蛋白病中tau蛋白的核磁共振研究
Front Mol Biosci. 2021 Nov 11;8:761227. doi: 10.3389/fmolb.2021.761227. eCollection 2021.
7
The structure and phase of tau: from monomer to amyloid filament.tau 结构与相态:单体至淀粉样纤维
Cell Mol Life Sci. 2021 Mar;78(5):1873-1886. doi: 10.1007/s00018-020-03681-x. Epub 2020 Oct 19.
9
14-3-3/Tau Interaction and Tau Amyloidogenesis.14-3-3/Tau 相互作用与 Tau 淀粉样蛋白形成。
J Mol Neurosci. 2019 Aug;68(4):620-630. doi: 10.1007/s12031-019-01325-9. Epub 2019 May 6.

本文引用的文献

1
Long-range correlated dynamics in intrinsically disordered proteins.固有无序蛋白质中的长程相关动力学。
J Am Chem Soc. 2014 Nov 19;136(46):16201-9. doi: 10.1021/ja506820r. Epub 2014 Nov 4.
6
Mechanistic basis of phenothiazine-driven inhibition of Tau aggregation.吩噻嗪驱动的 Tau 蛋白聚集抑制作用的机制基础。
Angew Chem Int Ed Engl. 2013 Mar 18;52(12):3511-5. doi: 10.1002/anie.201208290. Epub 2013 Feb 11.
8
Identification of an aggregation-prone structure of tau.鉴定 Tau 蛋白的易于聚集结构。
J Am Chem Soc. 2012 Oct 10;134(40):16607-13. doi: 10.1021/ja305206m. Epub 2012 Oct 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验